| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 293.67B | 281.87B | 270.22B | 254.97B | 246.45B | 256.35B |
| Gross Profit | 79.16B | 76.72B | 79.14B | 74.83B | 72.40B | 73.95B |
| EBITDA | 19.02B | 18.43B | 16.22B | 14.80B | 15.24B | 16.96B |
| Net Income | 9.63B | 9.01B | 7.44B | 6.36B | 7.07B | 8.28B |
Balance Sheet | ||||||
| Total Assets | 144.47B | 136.89B | 132.92B | 124.07B | 118.07B | 115.20B |
| Cash, Cash Equivalents and Short-Term Investments | 29.20B | 21.89B | 21.02B | 19.54B | 18.45B | 17.02B |
| Total Debt | 2.13B | 2.31B | 2.55B | 2.85B | 3.21B | 3.26B |
| Total Liabilities | 51.62B | 47.59B | 49.62B | 45.36B | 44.01B | 46.20B |
| Stockholders Equity | 92.84B | 89.29B | 83.30B | 78.70B | 74.06B | 69.00B |
Cash Flow | ||||||
| Free Cash Flow | 11.94B | 4.63B | 5.40B | 2.91B | 3.01B | 6.80B |
| Operating Cash Flow | 16.35B | 11.82B | 17.10B | 12.59B | 9.43B | 14.45B |
| Investing Cash Flow | -4.77B | -7.67B | -11.86B | -9.29B | -5.80B | -7.63B |
| Financing Cash Flow | -6.59B | -3.28B | -3.75B | -2.21B | -2.21B | -2.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥211.32B | 7.25 | ― | 2.18% | 6.30% | 27.88% | |
77 Outperform | ¥116.13B | 8.65 | ― | 2.53% | 5.57% | 27.41% | |
73 Outperform | ¥207.18B | 20.12 | 7.56% | 2.70% | 2.28% | 3.61% | |
63 Neutral | ¥232.64B | 17.32 | ― | 3.01% | 18.89% | -34.43% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥193.85B | -65.24 | ― | 1.77% | 30.67% | ― | |
57 Neutral | ¥194.52B | 100.03 | ― | 1.44% | 1.48% | -33.32% |